Sean LeBlanc
Overview
Explore the profile of Sean LeBlanc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perri M, Khorasheh T, Poon D, Kaminski N, LeBlanc S, Mizon L, et al.
Harm Reduct J
. 2023 Nov;
20(1):169.
PMID: 37964286
Background: The Canadian drug supply has significantly increased in toxicity over the past few years, resulting in the worsening of the overdose crisis. A key initiative implemented during this crisis...
2.
Kendall C, Boucher L, Donelle J, Martin A, Marshall Z, Boyd R, et al.
Can Fam Physician
. 2022 Feb;
68(2):117-127.
PMID: 35177504
Objective: To describe team-based care use among a cohort of people who use drugs (PWUD) and to determine factors associated with receipt of team-based care. Design: A cohort study using...
3.
Russell C, Ali F, Nafeh F, LeBlanc S, Imtiaz S, Elton-Marshall T, et al.
BMC Public Health
. 2021 Nov;
21(1):2021.
PMID: 34742267
Background: People who use drugs (PWUD) often have complex health and social support needs related to substance use, yet face numerous barriers to service access, resulting in unmet treatment needs...
4.
Rowlands Snyder E, Boucher L, Bayoumi A, Martin A, Marshall Z, Boyd R, et al.
PLoS One
. 2021 Jul;
16(7):e0253923.
PMID: 34197552
Introduction: Housing affects an individual's physical and mental health, particularly among people who use substances. Understanding the association between individual characteristics and housing status can inform housing policy and help...
5.
Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T
J Subst Abuse Treat
. 2021 Jun;
129:108427.
PMID: 34080561
No abstract available.
6.
Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T
J Subst Abuse Treat
. 2021 Jun;
129:108374.
PMID: 34080545
Introduction: Closures and reductions in capacity of select health and social services in response to the COVID-19 pandemic may have placed people who use drugs (PWUD) at a disproportionately increased...
7.
Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T
Int J Drug Policy
. 2021 Apr;
93:103237.
PMID: 33893026
Background: People who use drugs (PWUD) may be at an increased risk of experiencing negative effects related to COVID-19. Border and non-essential service closures may have placed PWUD at an...
8.
Kendall C, Boucher L, Donelle J, Martin A, Marshall Z, Boyd R, et al.
BMC Health Serv Res
. 2020 Sep;
20(1):837.
PMID: 32894114
Background: There may be less primary health care engagement among people who use drugs (PWUD) than among the general population, even though the former have greater comorbidity and more frequent...
9.
Boucher L, Bayoumi A, Mark A, Cooper C, Martin A, Marshall Z, et al.
Subst Use Misuse
. 2018 Jun;
54(1):18-30.
PMID: 29932800
Background: Chronic hepatitis C virus (HCV) infection is common among people who inject drugs (PWID) and is associated with morbidity and premature death. Although HCV can be cured, treatment may...
10.
Kendall C, Boucher L, Mark A, Martin A, Marshall Z, Boyd R, et al.
Harm Reduct J
. 2017 Jul;
14(1):42.
PMID: 28673291
No abstract available.